Wiki-annotating

By Jef Akst Wiki-annotating Colorized scanning electron micrograph of an electrically integrated network of bacteria. Photo by Bruce Arey and provided by Yuri Gorby Have you ever been told you couldn’t get funding because you weren’t asking for enough of it? Sounds absurd, right? That’s how Richard J. Roberts of New England Biolabs in Massachusetts felt when he heard over and over from funding agencies that they simply didn’t have a

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Have you ever been told you couldn’t get funding because you weren’t asking for enough of it? Sounds absurd, right? That’s how Richard J. Roberts of New England Biolabs in Massachusetts felt when he heard over and over from funding agencies that they simply didn’t have a mechanism to provide him with the series of small grants he was asking for—each $5,000 to $10,000 to annotate microbial genes of unknown function. He was hoping to provide the modest funds to labs that could quickly and cheaply annotate a wide range of genes. But the National Institutes of Health (NIH), the National Science Foundation, even the US Department of Energy all said the same thing—they couldn’t support such a project “because the amounts of money were smaller than they were used to dealing with,” Roberts recalls.

“I thought it was stupid [and] ridiculous,” he says. “To say, ‘That’s a good idea, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies